SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-21-028263
Filing Date
2021-11-15
Accepted
2021-11-12 21:13:05
Documents
53
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1256793
2 ex31-1.htm EX-31.1 12009
3 ex31-2.htm EX-31.2 11976
4 ex32-1.htm EX-32.1 9976
  Complete submission text file 0001493152-21-028263.txt   5873381

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE envb-20210930.xsd EX-101.SCH 49338
6 XBRL CALCULATION FILE envb-20210930_cal.xml EX-101.CAL 38807
7 XBRL DEFINITION FILE envb-20210930_def.xml EX-101.DEF 197755
8 XBRL LABEL FILE envb-20210930_lab.xml EX-101.LAB 392628
9 XBRL PRESENTATION FILE envb-20210930_pre.xml EX-101.PRE 293563
10 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 1027390
Mailing Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103 239-302-1707
Enveric Biosciences, Inc. (Filer) CIK: 0000890821 (see all company filings)

IRS No.: 954484725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38286 | Film No.: 211405823
SIC: 2834 Pharmaceutical Preparations